News/ News/ R&D Merck & Co adds COVID-19 drug to pipeline with OncoImmune buy Richard Staines COVID-19, M&A, Merck & Co, OncoImmune 0 Comment Merck & Co is to buy US biotech OncoImmune for at least $425m, adding a potential new therapy Share X Merck & Co adds COVID-19 drug to pipeline with OncoImmune buy https://pharmaphorum.com/news/merck-co-adds-covid-drug-to-pipeline-with-oncoimmune-buy/
